ICD-10 Coding for Fibrocystic Breast Changes(N60.0, N60.11, N60.11B)
Learn about the ICD-10 coding for fibrocystic breast changes, including documentation requirements and common coding pitfalls. Ensure accurate billing and compliance.
Complete code families applicable to Fibrocystic Breast Changes
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N60.19 | Diffuse Cystic Mastopathy, Unspecified | Use when fibrocystic changes are present without epithelial proliferation. |
|
| N60.11 | Diffuse Cystic Mastopathy, Right Breast | Use when fibrocystic changes are confirmed in the right breast. |
|
| N60.12 | Diffuse Cystic Mastopathy, Left Breast | Use when fibrocystic changes are confirmed in the left breast. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutFibrocystic Breast Changes
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Fibrocystic Breast Changes.
Omitting laterality in documentation
Impact
Clinical: May lead to misinterpretation of clinical findings., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.
Mitigation
Use templates that prompt for laterality, Review documentation for completeness before submission
Unspecified laterality
Impact
Reimbursement: May lead to claim denials or reduced reimbursement., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Decreases accuracy of clinical data.
Mitigation
Always specify laterality when coding fibrocystic changes.
Confusion with benign neoplasms
Impact
Reimbursement: Incorrect coding may affect DRG assignment., Compliance: Potential for audit issues., Data Quality: Impacts clinical data integrity.
Mitigation
Differentiate fibrocystic changes from benign neoplasms through imaging and biopsy.
Laterality Documentation
Impact
Failure to document laterality can lead to audit issues.
Mitigation
Implement mandatory fields for laterality in EHR templates.